WithdrawnNCT02625779
Combined Cytidine and Creatine-containing Drug in the Treatment of the Depression in bipolarity
This study assesses depression symptoms.
Medication studyAges 19–65South Korea
Understand this study
What is this study about?
This study assesses depression symptoms.
Who could participate?
Listed age limits: 19 years to 65 years.
- Listed locations
- SeoulSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: March 1, 2016
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- Ewha Womans University Mokdong Hospital
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- South Korea
- Age range
- From 19 Years to 65 Years
- Official registry ID
- NCT02625779
- Official title
Show the full official title
A Double-Blind, Placebo-Controlled Trial of Combined Cytidine- and Creatine-containing Drug and Dietary Supplement in the Treatment of the Bipolar Depression
Recruitment & locations
WithdrawnThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Seoul
Interested in joining this study?
Questions about this study
What is this study about?
This study assesses depression symptoms.
Who is behind this study?
The study sponsor is Ewha Womans University Mokdong Hospital, a university.
Does this study involve medication?
Yes. The study involves medication, including Valproate and Placebo, Valproate and Cytidine-containing Drug and Valproate and Creatine-containing Drug.
Who can participate?
Listed age limits: 19 years to 65 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
